Medicare Enrolled
Dr. David Svetec, MD
Urology Physician · Lancaster, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Svetec from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Svetec?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Svetec
Dr. David Svetec is an urology physician in Lancaster, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Svetec performed 5,080 Medicare services across 1,557 unique beneficiaries.
Between the years covered by Open Payments, Dr. Svetec received a total of $3,930 from 50 pharmaceutical and/or device companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Svetec is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in PA
$3,930 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,080
Medicare services
Top 10% in PA for urology physician
1,557
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~254 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,300 | $0 | $3 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
465 | $2 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
328 | $60 | $139 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $82 | $210 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
115 | $3 | $20 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
92 | $58 | $585 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $117 | $323 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
72 | $38 | $84 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
67 | $7 | $41 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
51 | $100 | $281 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
45 | $24 | $327 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
40 | $92 | $904 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
38 | $76 | $316 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
25 | $8 | $15 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
24 | $193 | $800 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $136 | $284 |
| PSA test (prostate cancer screening) | 18 | $18 | $120 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
17 | $64 | $211 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,930
Total received (2018-2024)
Avg $561/year across 7 years
Top 33% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
201
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,930 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$902
2023
$704
2022
$735
2021
$676
2020
$142
2019
$368
2018
$403
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$162
PFIZER INC.
$153
PROCEPT BioRobotics Corporation
$147
Janssen Biotech, Inc.
$92
Merck Sharp & Dohme LLC
$79
ABBVIE INC.
$59
Bayer Healthcare Pharmaceuticals Inc.
$49
AstraZeneca Pharmaceuticals LP
$40
Sumitomo Pharma America, Inc.
$39
180 Medical, Inc.
$27
Ambu Inc.
$24
Astellas Pharma US Inc
$18
COLOPLAST CORP
$15
Top 3 companies account for 51.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$456
Janssen Biotech, Inc.
$425
AstraZeneca Pharmaceuticals LP
$378
Astellas Pharma US Inc
$308
Dendreon Pharmaceuticals LLC
$237
Bayer HealthCare Pharmaceuticals Inc.
$217
Teleflex LLC
$162
Merck Sharp & Dohme LLC
$154
PROCEPT BioRobotics Corporation
$147
Sumitomo Pharma America, Inc.
$109
UROVANT SCIENCES INC
$102
Intuitive Surgical, Inc.
$90
Bayer Healthcare Pharmaceuticals Inc.
$83
Progenics Pharmaceuticals, Inc.
$81
Agiliti Surgical, Inc.
$73
ABBVIE INC.
$59
Coloplast Corp
$55
Ferring Pharmaceuticals Inc.
$53
Myovant Sciences Inc.
$50
COLOPLAST CORP
$49
TOLMAR Pharmaceuticals, Inc.
$47
UroGen Pharma, Inc.
$44
Foundation Medicine, Inc.
$41
ConvaTec Inc.
$38
Myriad Genetic Laboratories, Inc.
$37
Verity Pharmaceuticals Inc.
$33
180 Medical, Inc.
$27
Endo Pharmaceuticals Inc.
$26
Ambu Inc.
$24
Travere Therapeutics, Inc.
$22
Boston Scientific Corporation
$22
Blue Earth Diagnostics Limited
$21
Novartis Pharmaceuticals Corporation
$21
Merck Sharp & Dohme Corporation
$20
Baxter Healthcare
$20
ACCORD HEALTHCARE, INC.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
Kowa Pharmaceuticals America, Inc.
$15
Sun Pharmaceutical Industries Inc.
$15
BAXTER HEALTHCARE
$15
E.R. Squibb & Sons, L.L.C.
$14
Olympus America Inc.
$13
Amniox Medical, Inc.
$13
AbbVie, Inc.
$13
Axonics, Inc.
$12
Avadel Specialty Pharmaceuticals, LLC
$12
Accord Healthcare, Inc.
$12
Retrophin, Inc.
$11
Prometheus Laboratories Inc.
$11
Ethicon US, LLC
$11
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · Androgel · Axonics · Axumin · BOTOX · CAMCEVI · Da Vinci Surgical System · ECHELON FLEX Stapler · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · Flexiva · GEMTESA · GENTLECATH · JELMYTO · KEYTRUDA · LYNPARZA · MYRBETRIQ · NEOX · NOCDURNA · Noctiva · Nubeqa · OPDIVO · ORGOVYX · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Proleukin · Seglentis · Sonablate · SpeediCath · TISSEEL · Thiola · Trelstar · UROLIFT · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
48
Per 100K population
8.6
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Svetec is a mixed practice specialist, with above-average Medicare volume (top 10% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Svetec experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Svetec performed 3,300 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Svetec receive payments from pharmaceutical companies?
Yes. Dr. Svetec received a total of $3,930 from 50 companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Svetec's costs compare to other urology physicians in Lancaster?
Dr. Svetec's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Svetec) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lancaster
Browse urology physicians in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology